Hug, Peter, Ph.D.

Board of Directors

Peter Hug, Ph.D.

Board Observer

Dr. Peter Hug brings a wealth of global commercial and leadership experience to the board of directors of ADC Therapeutics. Dr. Hug is a 35-year veteran of Roche, where he held positions of increasing responsibility until his retirement at the end of 2018. Most recently, he served as Head of Roche Pharma EEMEA Region, which comprises Eastern Europe, Russia, Central Asia, Turkey, Middle East and Africa. Previously, he was Head of Pharma Region Europe, during which time he led a successful transformation of its European commercial operations. Prior to that, Dr. Hug served as Executive Vice President of Roche Pharma Partnering, a role in which he was responsible for licensing, strategic alliances and mergers and acquisitions. In earlier management roles within Roche, he was involved with multiple product launches, including hematology and oncology therapies.

Dr. Hug is a graduate of the University of Basel, Switzerland. He is also a Board Member and Vice Chairman of the Swiss Post, and he was President of Interpharma (Swiss Pharma Association) until the end of 2018.